We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$15.3B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12B
AUM Growth
+$2B
(+20%)
Cap. Flow
+$2.04B
Cap. Flow
% of AUM
17.04%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
107
New
26
Increased
43
Reduced
12
Closed
21
Top Buys
| 1 |
COL
Rockwell Collins
COL
|
+$391M |
| 2 |
MON
Monsanto Co
MON
|
+$386M |
| 3 |
Keurig Dr Pepper
KDP
|
+$362M |
| 4 |
LOGM
LogMein, Inc.
LOGM
|
+$212M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$182M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$306M |
| 2 |
AABA
Altaba Inc
AABA
|
+$248M |
| 3 |
AB InBev
BUD
|
+$164M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$163M |
| 5 |
Huntsman Corp
HUN
|
+$80.7M |
Sector Composition
| 1 | Technology | 25.94% |
| 2 | Healthcare | 17.57% |
| 3 | Communication Services | 16.49% |
| 4 | Financials | 13.71% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alnylam Pharmaceuticals
ALNY
$38.5B
| $44.1M | 0.37% |
+370,000
| New | +$47.7M |
|
52
VEON
VEON
$3.6B
| $40.9M | 0.34% |
620,040
-557,301
| -47% | -$46.7M |
|
53
NovoCure
NVCR
$1.86B
| $40.3M | 0.34% |
1,850,000
+685,000
| +59% | +$14.7M |
|
|
AVXS
54
DELISTED
AveXis, Inc. Common Stock
AVXS
| $36.3M | 0.3% |
+294,000
| New | +$34.9M |
|
|
RC
55
Ready Capital
RC
$266M
| $33.5M | 0.28% |
2,208,239
+8,232
| +0.4% | +$120K |
|
|
LKFT
56
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.95B
| $30.8M | 0.26% |
308,260
+18,260
| +6% | +$1.97M |
|
57
Cigna
CI
$80.6B
| $30.2M | 0.25% |
+180,000
| New | +$35M |
|
58
CRISPR Therapeutics
CRSP
$4.99B
| $29.5M | 0.25% |
645,000
-213,602
| -25% | -$8.82M |
|
|
BMS
59
DELISTED
Bemis
BMS
| $24.5M | 0.2% |
562,500
+502,500
| +838% | +$22.9M |
|
60
Avista
AVA
$3.48B
| $20.5M | 0.17% |
+400,000
| New | +$20.2M |
|
61
Savara
SVRA
$1.18B
| $20.5M | 0.17% |
2,225,000
| – | – |
|
62
Hain Celestial
HAIN
$50.8M
| $17.5M | 0.15% |
545,000
+255,000
| +88% | +$9.26M |
|
63
Voyager Therapeutics
VYGR
$196M
| $16.7M | 0.14% |
890,000
+235,188
| +36% | +$5.08M |
|
|
EVHC
64
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $14M | 0.12% |
+365,000
| New | +$13.6M |
|
|
AMRN
65
Amarin Corp
AMRN
$308M
| $13.7M | 0.11% |
+228,000
| New | +$16.9M |
|
66
Intellia Therapeutics
NTLA
$1.82B
| $13.7M | 0.11% |
650,000
-490,000
| -43% | -$12.1M |
|
|
ZEAL
67
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $13M | 0.11% |
865,000
+215,000
| +33% | +$3.34M |
|
|
CCXI
68
DELISTED
ChemoCentryx, Inc.
CCXI
| $12.9M | 0.11% |
+950,000
| New | +$9.8M |
|
69
Tronox
TROX
$976M
| $12.7M | 0.11% |
688,006
+498,631
| +263% | +$9.93M |
|
|
BOLD
70
DELISTED
Audentes Therapeutics, Inc
BOLD
| $9.62M | 0.08% |
320,000
+338
| +0.1% | +$11.4K |
|
|
CBI
71
DELISTED
Chicago Bridge & Iron Nv
CBI
| $9.5M | 0.08% |
+660,000
| New | +$12.1M |
|
72
Voya Financial
VOYA
$8.97B
| $9.34M | 0.08% |
+185,000
| New | +$9.55M |
|
|
SYBX
73
DELISTED
Synlogic
SYBX
| $9.15M | 0.08% |
+65,000
| New | +$10.1M |
|
|
AHL
74
DELISTED
ASPEN Insurance Holding Limited
AHL
| $8.72M | 0.07% |
+194,341
| New | +$7.62M |
|
75
Protagonist Therapeutics
PTGX
$8.35B
| $8.71M | 0.07% |
1,013,500
+113,500
| +13% | +$2.14M |
|
Similar funds
UM
RFC
HWM
NMO
EH
MSV